ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 726089 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 726089; 2) Community: the network communities that were significantly associated with the response to NSC 726089; 3) Molecule: the relationships between components within communities and NSC 726089; 4) MDR: the compounds that were significantly associated with the NSC 726089.

NSC Compound Enrichment Correlation
NSC 606499 Camptothecin Derivative 0.0321614375606955 0.11095818
NSC 673652 2-Ethylaminoestradiol 0.0321614375606955 -0.0053146365
NSC 683556 Camptothecin Derivative 0.0321614375606955 0.089809406
NSC 759016 Null 0.0321614375606958 0.30606851
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.0321614375606959 0.42041671
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0321614375606959 0.48531555
NSC 633271 Null 0.0321614375606959 0.45354201
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.0321614375606959 0.38676879
NSC 639645 Null 0.0321614375606959 0.10662445
NSC 661581 2-Azabicyclo[16.3.1]docosane, geldanamycin deriv. 0.0321614375606959 0.46965049
Total:65  Current:42    [First] [Prev] [Next] [Last]